ProCE Banner Series

10th Annual Psychopharmacology Update 2024

Join us for the live 10th Annual Psychopharmacology Update 2024, which will be presented online and in person. This free comprehensive 2-day conference will explore the latest advances in the pharmacotherapy of psychiatric illness. Register early to secure your seat!

  AAPA
  | ACPE
  | ADA CERP
  | AMA
  | ANCC with Pharmacotherapy Credit
  | APA
  | ASWB ACE
  | COPE
Who Should Attend

This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with psychiatric illness.

All Events

10th Annual Psychopharmacology Update 2024

Past Events

December

06

2024

8:00 AM - 4:30 PM Eastern Time (ET)

In-personVirtual

The Diplomat Beach Resort, 3555 South Ocean Drive, Hollywood, Florida 33019

Faculty

ProCE Banner Faculty
Lori L. Davis, MD

Adjunct Professor of Psychiatry
University of Alabama School of Medicine
Birmingham, Alabama

ProCE Banner Faculty
Stephen A. Givens, PhD, LPC, NCC

CEO, Licensed Professional Counselor
The Counseling & Wellness Center
 

ProCE Banner Faculty
Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

ProCE Banner Faculty
Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

ProCE Banner Faculty
John M. Kane, MD

Co-Director, Institute of Behavioral Science
Feinstein Institutes for Medical Research
Professor, Psychiatry and Molecular Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
New York, New York

ProCE Banner Faculty
Heather Luing, MD

For Intra-Cellular Therapies, Inc
Medical Director
Florida Center for TMS
Attending Psychiatris, Department of Psychiatry
University of Florida at Flagler Hospital
St. Augustine, Florida

 

ProCE Banner Faculty
Vladimir Maletic, MD, MS

Clinical Professor of Psychiatry
University of South Carolina
Greenville, South Carolina

ProCE Banner Faculty
John S. Markowitz, PharmD, BCPP

Professor
University of Florida College of Pharmacy
Department of Pharmacotherapy and Translational Research
Gainesville, Florida

ProCE Banner Faculty
Greg W Mattingly, MD

Founding Partner, St. Charles Psychiatric Associates
St. Charles, Missouri
President, Midwest Research Group
St. Louis, Missouri

ProCE Banner Faculty
Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
University of Toronto
Toronto, Canada

ProCE Banner Faculty
Jennifer L. Payne, MD

Professor and Vice Chair of Research
Department of Psychiatry and Neurobehavioral Sciences
University of Virginia
Charlottesville, Virginia

ProCE Banner Faculty
Anton P. Porsteinsson, MD

William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
Director, Alzheimer's Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

ProCE Banner Faculty
Michael Sprintz, DO, DFASAM

Subject Matter Expert in Chronic Pain and Addiction
Founder, Sprintz Center for Pain and Recovery
The Woodlands, Texas

Topics

Tentative Topics:

  • GLP-1 and Mental Health
  • Agitation, Psychosis, and Behavioral Challenges in Alzheimer’s Disease
  • Novel Treatment Options for Schizophrenia
  • Major Depressive Disorder
  • Tardive Dyskinesia
  • Substance Use Disorder
  • Hormones and Depression
  • Cannabis
  • Post Traumatic Stress Disorder
  • Clinical Reasoning in Psychiatry

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Target Audience
This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Discuss the latest advances in the pharmacologic management of psychiatric disorders
  • Implement evidence-based pharmacotherapy for treatment of psychiatric disorders
  • Individualize treatment choices for psychiatric disorders based on efficacy, safety, and patient characteristics

*Pain Management Topic Only
Target Audience

This program is designed to educate HCPs in the United States, particularly HCPs practicing in settings with multidisciplinary and interprofessional healthcare teams, including physicians, advanced practice nurses, physician associates, pharmacists, nurses, psychologists, social workers, dental professionals, and optometrists. Specialty areas include, but are not limited to, physiatry, psychiatry, neurology, family medicine, internal medicine, pain management, and surgery.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify fundamental concepts of pain management, including mechanisms of pain; risk factors for misuse, abuse, and opioid use disorder; and appropriate assessment of pain
  • Create an individualized, patient-specific pain treatment plan that safely and effectively integrates the range of therapeutic options, including initiating therapy, titrating, and discontinuing non-opioid medications and opioid analgesics
  • Design an individualized patient and caregiver education plan on the safe use, storage, and disposal of opioid analgesics and the role of reversal agents
  • Construct a systematic approach to screening for and appropriately managing patients with opioid use disorder

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 12.0 contact hours, including 12.0 hours of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 12.0 contact hours (1.2 CEUs) of the Accreditation Council for Pharmacy Education. UAN: will be specific to each topic 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 12.0 continuing education credits for psychologists

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 12.0 clinical continuing education credits.

Dental Professionals Continuing Education
*Pain Management Topic Only 

Clinical Care Options, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Clinical Care Options, LLC designates this activity for 2.5 continuing education credits.

Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Optometrist Continuing Education
*Pain Management Topic Only 

Clinical Care Options, LLC designates this synchronous in-person/virtual activity for a maximum of 2.5 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.

ABMS Approval Statement

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Innovation Insight: How are Novel Agents Reshaping Schizophrenia's Landscape?; Clusters of Concerns: Neurobiology and Treatment of Psychiatric Disorder Comorbidities; Insights into Tardive Dyskinesia in Aging Populations; Agitation, Psychosis, and Other Behavioral Issues in Alzheimer’s Dementia; Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers; Sutures, Psych, and Sobriety: Tying together psychiatric post-op support for at-risk patients; Estrogen and Mood: Psychiatric Considerations Over the Reproductive Lifecycle; Navigating Cannabis Use in Psychiatric Populations: Drug-Drug Interactions and Other Pharmacologic Considerations; Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail; Do Obesity and Diabetes Mellitus Metastasize to the Brain? "Metaboptosis" and Implications for Potential Therapeutics in Psychiatry, has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Bristol Myers Squibb; Neurocrine Biosciences, Inc.; and Otsuka America Pharmaceutical, Inc. and Lundbeck.


*Pain Management Topic Only

Provided by Clinical Care Options, LLC and in partnership with the Alliance to Advance Comprehensive Integrative Pain Management, American Academy of Physical Medicine and Rehabilitation, Practicing Clinicians Exchange, and ProCE

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).